Chen Schor - 24 Jan 2025 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
President & CEO, Director
Signature
/s/ Nick Harvey, Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
24 Jan 2025
Net transactions value
-$25,904
Form type
4
Filing time
28 Jan 2025, 16:29:04 UTC
Previous filing
07 Jun 2024
Next filing
04 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Tax liability $25,904 -28,101 -17% $0.9218 137,201 24 Jan 2025 Direct F1
holding ACET Common Stock 43,469 24 Jan 2025 See Footnote F2
holding ACET Common Stock 53,424 24 Jan 2025 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.
F2 Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee.
F3 Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.

Remarks:

The number of securities beneficially owned as reported in each column (5) reflects ownership as of the date of this filing based on available records of the Reporting Person and other information provided to the Issuer and reflects the correct allocation of the Reporting Person's shares among various accounts. Prior Form 4 filings made by the Reporting Person on October 2, 2023 and January 24, 2024 inadvertently overstated the aggregate number of securities beneficially owned by Reporting Person by 43,469 shares. The Reporting Person has corrected the inadvertent overstatement in this Form 4 filing across applicable accounts.